Literature DB >> 17487566

Hypertension and kidney protection in the elderly: what is the evidence in 2007?

Robert D Lindeman1.   

Abstract

Hypertension and diabetes mellitus are the two most widely recognized risk factors for cardiovascular disease (CVD), chronic kidney disease (CKD), and end-stage renal disease (ESRD) requiring dialysis/transplantation; both become increasingly important as one ages. Common pathways and mechanisms are involved in the development of renal vascular lesions in both conditions, and effective treatments for each are now available to reduce morbidity, mortality and progression of organ damage. Although this review will focus primarily on the ability to protect the kidney and vasculature elsewhere by lowering blood pressure in the elderly, other approaches, specifically dietary restriction of protein, strict control of diabetes mellitus, and the management of the different dyslipidemias, must be used in conjunction with the antihypertensive agents to obtain optimum protection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487566     DOI: 10.1007/s11255-007-9207-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  67 in total

Review 1.  Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications.

Authors:  M Epstein
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

2.  The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials.

Authors:  R W Schrier; R O Estacio
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

Review 3.  Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?

Authors:  Norman K Hollenberg; Murray Epstein
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-19       Impact factor: 8.237

Review 4.  Systolic hypertension in older persons.

Authors:  Sarwat I Chaudhry; Harlan M Krumholz; JoAnne Micale Foody
Journal:  JAMA       Date:  2004-09-01       Impact factor: 56.272

Review 5.  Pathophysiology of hypertensive renal damage: implications for therapy.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

Review 6.  Aldosterone in the development and progression of renal injury.

Authors:  Norman K Hollenberg
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

7.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

8.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Authors:  G Maschio; D Alberti; G Janin; F Locatelli; J F Mann; M Motolese; C Ponticelli; E Ritz; P Zucchelli
Journal:  N Engl J Med       Date:  1996-04-11       Impact factor: 91.245

9.  Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.

Authors:  Murray Epstein; Gordon H Williams; Myron Weinberger; Andrew Lewin; Scott Krause; Robin Mukherjee; Rajiv Patni; Bruce Beckerman
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-19       Impact factor: 8.237

10.  Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

Authors: 
Journal:  BMJ       Date:  1992-02-15
View more
  5 in total

1.  Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.

Authors:  Ai-Hua Zhang; Paul Tam; Denise LeBlanc; Hui Zhong; Christopher T Chan; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-07-04       Impact factor: 2.370

2.  Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study.

Authors:  Li-Yan Wang; Dao-Xin Yin; Dong-Liang Zhang; Rui Xu; Wen-Ying Cui; Wen-Hu Liu
Journal:  Int Urol Nephrol       Date:  2012-12-07       Impact factor: 2.370

3.  Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic.

Authors:  Hulya Taskapan; Paul Tam; Victoria Au; Stephen Chow; Jason Fung; Gordon Nagai; Janet Roscoe; Paul Ng; Tabo Sikaneta; Robert Ting; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-02       Impact factor: 2.370

4.  Establishing a renal management clinic in China: initiative, challenges, and opportunities.

Authors:  Ai-Hua Zhang; Hui Zhong; Wen Tang; Shao-Yan Chen; Lian He; Song Wang; Chun Yan Su; Xin-Hong Lu; Tao Wang
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

5.  Should prevention of chronic kidney disease start before pregnancy?

Authors:  Guido Filler; Meera S Rayar; Orlando da Silva; Ilan Buffo; Dion Pepelassis; Ajay P Sharma
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.